Approval and Monitoring of Narcotic Treatment Programs: A Guide on the Roles of Federal and State Agencies
|
NIDA is currently funding a feasibility study for the development of a Methadone Treatment Quality Assurance System (MTQAS). The goal of the project is to examine the feasibility of implementing a performance-based reporting and feedback system in methadone treatment programs and whether such a system would be useful in measuring treatment effectiveness. Preliminary MTQAS data are expected to be available by the spring of 1994.
Concern over the increase in HIV, TB, and STD infection rates among injecting drug users has prompted Federal policy makers to explore options for increasing the intensity of primary health services to methadone patients. CSAT is currently exploring models for using MMTPs to demonstrate the effectiveness of linking these public health issues, and NIDA is also funding a number of studies in this area.
The Interagency Methadone Policy Review <R>Board provides a forum to discuss and review major policy issues related to methadone. The FDA, DEA, NIDA, and CSAT are represented on this board, in addition to the Veterans Administration and other Federal policy offices involved in substance abuse treatment.
| << Back | Table of Content | Next >> |